These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17372814)

  • 1. The worldwide social burden of atrial fibrillation: what should be done and where do we go?
    Santini M; Ricci RP
    J Interv Card Electrophysiol; 2006 Dec; 17(3):183-8. PubMed ID: 17372814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid therapy of atrial fibrillation.
    Santini M; Pignalberi C; Ricci R; Calò L
    Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid therapy in the management of atrial fibrillation.
    Starek Z; Lehar F; Jez J; Wolf J; Novák M
    Curr Cardiol Rev; 2015; 11(2):167-79. PubMed ID: 25028165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of rhythm control in persistent or permanent atrial fibrillation with overdrive atrial pacing and antiarrhythmic drugs after linear right atrial catheter ablation.
    Filipecki A; Saksena S; Lin WH
    Am J Cardiol; 2003 Nov; 92(9):1037-44. PubMed ID: 14583353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation.
    Prakash A; Saksena S; Krol RB; Filipecki A; Philip G
    J Interv Card Electrophysiol; 2002 Jun; 6(2):165-72. PubMed ID: 11992027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology and therapy of atrial fibrillation].
    Capucci A; Aschieri D; Villani GQ
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():5S-10S. PubMed ID: 9004821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The place of hybrid therapies with drugs to supplement nonpharmacological therapies in atrial fibrillation.
    Govindan M; Catanchin A; Camm AJ
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):210-21. PubMed ID: 18806601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approaches to atrial fibrillation management: a critical review of a rapidly evolving field.
    Nattel S; Khairy P; Roy D; Thibault B; Guerra P; Talajic M; Dubuc M
    Drugs; 2002; 62(16):2377-97. PubMed ID: 12396229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the non-surgical management of atrial fibrillation.
    Kamalvand K; Sulke N
    Int J Clin Pract; 1999; 53(1):44-9. PubMed ID: 10344066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpharmacologic strategies for treating atrial fibrillation.
    Lüderitz B; Pfeiffer D; Tebbenjohanns J; Jung W
    Am J Cardiol; 1996 Jan; 77(3):45A-52A. PubMed ID: 8607391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhythm versus rate control after ablation and pacing for paroxysmal atrial fibrillation: clinical implications of the PAF 2 trial.
    Brignole M
    Card Electrophysiol Rev; 2003 Jun; 7(2):127-9. PubMed ID: 14618035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced electrophysiologic mapping systems: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(8):1-101. PubMed ID: 23074499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial.
    Blomström-Lundqvist C; Gizurarson S; Schwieler J; Jensen SM; Bergfeldt L; Kennebäck G; Rubulis A; Malmborg H; Raatikainen P; Lönnerholm S; Höglund N; Mörtsell D
    JAMA; 2019 Mar; 321(11):1059-1068. PubMed ID: 30874754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of pacing in rhythm control and management of atrial fibrillation.
    Silberbauer J; Sulke N
    J Interv Card Electrophysiol; 2007 Mar; 18(2):159-86. PubMed ID: 17473977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation.
    Madan N; Saksena S
    Am J Cardiol; 2004 Mar; 93(5):569-75. PubMed ID: 14996581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.
    Teo WS; Kam R; Tan A
    Ann Acad Med Singap; 1998 Mar; 27(2):248-54. PubMed ID: 9663319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-pharmacological treatments for atrial fibrillation. A critical perspective on the status quo.
    Murgatroyd FD; Leenhardt A
    Arch Mal Coeur Vaiss; 2000 Apr; 93(3 Spec No):7-16. PubMed ID: 10816796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
    Brignole M; Menozzi C; Gasparini M; Bongiorni MG; Botto GL; Ometto R; Alboni P; Bruna C; Vincenti A; Verlato R;
    Eur Heart J; 2002 Jun; 23(11):892-900. PubMed ID: 12042011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Can atrial fibrillation be managed without anti-arrhythmia drugs?].
    Blanc JJ; Mansourati J
    Arch Mal Coeur Vaiss; 1994 Sep; 87 Spec No 3():63-7. PubMed ID: 7786126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.